Literature DB >> 2760646

Skeletal muscle CK-B activity in neurogenic muscular atrophies.

E Vretou-Jockers1, D Vassilopoulos.   

Abstract

Creatine kinase isoenzymes were determined in skeletal muscle biopsy specimens of 34 patients suffering from neurogenic muscular atrophies. The findings were compared: (1) with those of 38 control muscle samples and (2) with those in 41 muscular dystrophies and other myopathic conditions. The measurements were made by electrophoretic separation and elution of the isoenzymes and by immunoinhibition assay. The results showed that the total and specific CK activity were significantly decreased (P less than 0.005) in neurogenic atrophies in contrast to myopathic conditions where no differences from control levels were observed. This decrease was due to a decrease of the CK-M subunit activity, while the CK-B subunit was elevated. The muscle CK-MB activity was considerably elevated in muscular dystrophies (P less than 0.02) and myositis (P less than 0.001), but it was also slightly elevated in neurogenic conditions. The similarity of the muscle CK isoenzyme pattern in neurogenic atrophies and myotonic dystrophy was noted. These findings could possibly reflect considerable difference in the regeneration process of neurogenic atrophies and muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760646     DOI: 10.1007/BF00314457

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

1.  THE ONTOGENY OF CREATINE KINASE ISOZYMES.

Authors:  H M EPPENBERGER; M EPPENBERGER; R RICHTERICH; H AEBI
Journal:  Dev Biol       Date:  1964-08       Impact factor: 3.582

2.  Serum creatine kinase isoenzyme pattern in nervous system atrophies and neuromuscular disorders.

Authors:  E Jockers-Wretou; K Grabert; E Müller; G Pfleiderer
Journal:  Clin Chim Acta       Date:  1976-11-15       Impact factor: 3.786

3.  Serum and muscle creatine kinase isoenzymes and serum aspartate aminotransferase isoenzymes in progressive muscular dystrophy.

Authors:  A Cao; S De Virgiliis; C Lippi; G Coppa
Journal:  Enzyme       Date:  1971

Review 4.  Molecular and cell isoforms during development.

Authors:  A I Caplan; M Y Fiszman; H M Eppenberger
Journal:  Science       Date:  1983-09-02       Impact factor: 47.728

5.  Developmental regulation of creatine kinase isoenzymes in myogenic cell cultures from chicken. Levels of mRNA for creatine kinase subunits M and B.

Authors:  J C Perriard
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

6.  Creatine kinase isoenzymes in neuromuscular diseases.

Authors:  H Somer; V Dubowitz; M Donner
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

7.  Creatine phosphokinase isozymes in muscles. Human fetus and patients.

Authors:  I Goto; M Nagamine; S Katsuki
Journal:  Arch Neurol       Date:  1969-04

8.  Creatine kinase isoenzymes in extracts of various human skeletal muscles.

Authors:  J S Tsung; S S Tsung
Journal:  Clin Chem       Date:  1986-08       Impact factor: 8.327

9.  Creatine kinase isoenzyme MM variants in skeletal muscle and plasma from marathon runners.

Authors:  F S Apple; M A Rogers; J L Ivy
Journal:  Clin Chem       Date:  1986-01       Impact factor: 8.327

10.  Creatine kinase isoenzymes in cultured human muscle cells. I. Comparison of Duchenne muscular dystrophy with other myopathic and neurogenic disease.

Authors:  G I Franklin; N P Cavanagh; B P Hughes; R Yasin; E J Thompson
Journal:  Clin Chim Acta       Date:  1981-09-10       Impact factor: 3.786

View more
  1 in total

1.  Biochemical Markers of Myocardial Damage.

Authors:  Geza S Bodor
Journal:  EJIFCC       Date:  2016-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.